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Abstract: Sudden cardiac death (SCD) is the leading cause of mortality in athletes during sport. A
variety of mostly hereditary, structural, or electrical cardiac disorders are associated with SCD in young
athletes, the majority of which can be identified or suggested by abnormalities on a resting 12-lead
electrocardiogram (ECG). Whether used for diagnostic or screening purposes, physicians responsible
for the cardiovascular care of athletes should be knowledgeable and competent in ECG interpretation in
athletes. However, in most countries a shortage of physician expertise limits wider application of the ECG
in the care of the athlete. A critical need exists for physician education in modern ECG interpretation that
distinguishes normal physiological adaptations in athletes from distinctly abnormal findings suggestive
of underlying pathology. Since the original 2010 European Society of Cardiology recommendations for
ECG interpretation in athletes, ECG standards have evolved quickly over the last decade; pushed by
a growing body of scientific data that both tests proposed criteria sets and establishes new evidence
to guide refinements. On February 26-27, 2015, an international group of experts in sports cardiology,
inherited cardiac disease, and sports medicine convened in Seattle, Washington, to update contemporary
standards for ECG interpretation in athletes. The objective of the meeting was to define and revise ECG
interpretation standards based on new and emerging research and to develop a clear guide to the proper
evaluation of ECG abnormalities in athletes. This statement represents an international consensus for
ECG interpretation in athletes and provides expert opinion-based recommendations linking specific ECG
abnormalities and the secondary evaluation for conditions associated with SCD.
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ABSTRACT
Sudden cardiac death (SCD) is the leading cause of mortality in athletes during sport. A variety of mostly hereditary,
structural, or electrical cardiac disorders are associated with SCD in young athletes, the majority of which can be iden-
tified or suggested by abnormalities on a resting 12-lead electrocardiogram (ECG). Whether used for diagnostic or
screening purposes, physicians responsible for the cardiovascular care of athletes should be knowledgeable and
competent in ECG interpretation in athletes. However, in most countries a shortage of physician expertise limits wider
application of the ECG in the care of the athlete. A critical need exists for physician education in modern ECG interpre-
tation that distinguishes normal physiological adaptations in athletes from distinctly abnormal findings suggestive of
underlying pathology. Since the original 2010 European Society of Cardiology recommendations for ECG interpretation in
athletes, ECG standards have evolved quickly over the last decade; pushed by a growing body of scientific data that both
tests proposed criteria sets and establishes new evidence to guide refinements. On February 26-27, 2015, an international
group of experts in sports cardiology, inherited cardiac disease, and sports medicine convened in Seattle, Washington, to
update contemporary standards for ECG interpretation in athletes. The objective of the meeting was to define and revise
ECG interpretation standards based on new and emerging research and to develop a clear guide to the proper evaluation
of ECG abnormalities in athletes. This statement represents an international consensus for ECG interpretation in athletes
and provides expert opinion-based recommendations linking specific ECG abnormalities and the secondary evaluation for
conditions associated with SCD. (J Am Coll Cardiol 2017;69:1057–75) © 2017 The Authors. Published by Elsevier Inc. on
behalf of American College of Cardiology Foundation. All rights reserved.
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INTRODUCTION
Cardiovascular-related sudden death is the
leading cause of mortality in athletes during
sport and exercise (1–3). The majority of
disorders associated with an increased risk of
sudden cardiac death (SCD) are suggested or
identified by abnormalities on a resting
12-lead ECG. Whether used for the evaluation
of cardiovascular-related symptoms, a family
history of inheritable cardiac disease or
premature SCD, or for screening of asymp-
tomatic athletes, ECG interpretation is an
essential skill for all physicians involved in
the cardiovascular care of athletes.
THE 2015 SUMMIT ON ECG INTERPRETATION
IN ATHLETES. Over the last decade, ECG
interpretation standards have undergone
several modifications to improve the accu-
racy of detecting potentially life threatening
cardiac conditions in young athletes while
also limiting false positive results (4–15). In
February 2015, an international group of
experts convened in Seattle, Washington, to
update contemporary recommendations for
ECG interpretation in asymptomatic athletes
age 12 to 35 years. The goals of the summit
meeting were to: 1) update ECG interpreta-
tion standards based on new and emerging
research; and 2) develop a clear guide to the
appropriate evaluation of ECG abnormalities
for conditions associated with SCD in ath-
letes. In the presence of cardiac symptoms or
a family history of inherited cardiovascular
disease or premature SCD, a normal ECG
should not preclude further assessment.
This document provides the most updated
evidence-based recommendations developed with
thoughtful attention to balance sensitivity and
specificity, while maintaining a clear and practical
checklist of findings to guide ECG interpretation for
physicians and the appropriate evaluation of ECG
abnormalities. A summary of the consensus recom-
mendations is presented in Figure 1 and Tables 1 and 2.
LIMITATIONS. While ECG increases the ability to
detect underlying cardiovascular conditions associ-
ated with SCD, ECG as a diagnostic tool has limitations
in both sensitivity and specificity. Specifically, ECG is
unable to detect anomalous coronary arteries, pre-
mature coronary atherosclerosis, and aortopathies. In
some instances patients with cardiomyopathies,
particularly arrhythmogenic right ventricular cardio-
myopathy (ARVC), may also reveal a normal ECG.
Thus, an ECG will not detect all conditions predis-
posing to SCD. Furthermore, inter-observer variability
among physicians remains a major concern (16–18),
despite studies demonstrating that using standard-
ized criteria improves interpretation accuracy (19,20).
NORMAL ECG FINDINGS IN ATHLETES
PHYSIOLOGICAL CARDIAC ADAPTATIONS TO REGULAR
EXERCISE. Regular and long-term participation in
intensive exercise (minimum of 4 h per week) is
associated with unique electrical manifestations that
reflect enlarged cardiac chamber size and increased
vagal tone. These ECG findings in athletes are
considered normal, physiological adaptations to reg-
ular exercise and do not require further evaluation
(Figure 1, Table 1).
LEFT AND RIGHT VENTRICULAR HYPERTROPHY. The
presence of isolated QRS voltage criterion for left
ventricular hypertrophy (LVH) (Figure 2) does
not correlate with pathology in athletes and is
present in isolation (without other associated ECG
abnormalities) in <2% of patients with hypertrophic
ABBR EV I A T I ON S
AND ACRONYMS
ARVC = arrhythmogenic right
ventricular cardiomyopathy
AV = atrioventricular
BrS = Brugada syndrome






LBBB = left bundle branch
block
LGE = late gadolinium
enhancement
LQTS = long QT syndrome
LVH = left ventricular
hypertrophy
LVNC = left ventricular
noncompaction
MRI = magnetic resonance
imaging
RBBB = right bundle branch
block
RVH = right ventricular
hypertrophy
SAECG = signal average
electrocardiogram
SCD = sudden cardiac death
SVT = supraventricular
tachycardia
TWI = T-wave inversion
VF = ventricular fibrillation
VPC = ventricular premature
contractions
WPW = Wolf–Parkinson–White
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cardiomyopathy (HCM) (21–27). Conversely, patho-
logical LVH is commonly associated with additional
ECG features such as T-wave inversion (TWI) in the
inferior and lateral leads, ST-segment depression,
and pathological Q waves (28,29). Therefore, the iso-
lated presence of high QRS voltages fulfilling voltage
criterion for LVH in the absence of other ECG or
clinical markers suggestive of pathology are consid-
ered part of normal and training-related ECG changes
in athletes and does not require further evaluation.
Voltage criterion for right ventricular hypertrophy
(RVH) is also common in athletes with up to 13% of
athletes fulfilling the Sokolow–Lyon index (30,31). QRS
voltages for RVH, when present in isolation, do not
correlate with underlying pathology in athletes (31).
Similar to voltage criteria for LVH, isolatedQRS voltage
for RVH is part of the normal spectrum of ECG findings
in athletes and does not require further evaluation.
EARLY REPOLARIZATION. Early repolarization is
defined as elevation of the QRS-ST junction (J-point)
by$0.1 mV often associated with a late QRS slurring or
notching (J-wave) affecting the inferior and/or lateral
leads (32–34). Early repolarization is common in
healthy populations (2% to 44%) and is more prevalent
in athletes, young individuals, males, and black
ethnicity (32,35–39). Early repolarization consisting of
J-point elevation with concave ST-segment elevation
and a peaked TWI (Figure 2) is present in up to 45% of
Caucasian athletes and 63% to 91% of black athletes of
African-Caribbean descent (hereto referred to as
‘black’ athletes) (22,30).
Some studies on survivors of cardiac arrest and pa-
tients with primary ventricular fibrillation (VF) have
suggested an association between early repolarization
and the risk of VF (33,40). Although further studies are
warranted to fully elucidate the mechanisms and
prognostic implications of early repolarization in
competitive athletes, to date there are no data to sup-
port an association between inferior early repolariza-
tion and SCD in athletes. Based on current evidence, all
patterns of early repolarization, when present in
isolation and without clinical markers of pathology,
should be considered benign variants in athletes (41).
REPOLARIZATION FINDINGS IN BLACK ATHLETES.
Ethnicity is a major determinant of cardiac adaptation
to exercise with more than two-thirds of black athletes
exhibiting repolarization changes (29,30,42,43). Black
athletes also commonly demonstrate a repolarization
















ST elevation followed by 
T wave inversion V1-V4 in
black athletes
T wave inversion V1-V3 
age <16 years old
Sinus bradycardia or
arrhythmia
Ectopic atrial or junctional
rhythm
1˚ AV block


























Brugada Type 1 pattern
Profound sinus bradycardia
< 30 bpm
PR interval ≥ 400 ms
















No further evaluation required
in asymptomatic athletes with no
family history of inherited cardiac
disease or SCD
Further evaluation required
to investigate for pathologic
cardiovascular disorders associated
with SCD in athletes
In isolation 2 or more
AV ¼ atrioventriular block; LBBB ¼ left bundle branch block; LVH ¼ left ventricular hypertrophy; RBBB ¼ right bundle branch block;
RVH ¼ right ventricular hypertrophy; PVC ¼ premature ventricular contraction; SCD ¼ sudden cardiac death.
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variant consisting of J-point elevation and convex
ST-segment elevation in the anterior leads (V1 to V4)
followed by TWI (Figures 3, 4B, and 4C) which is
regarded as a normal variant and should not result in
further investigation, in the absence of other clinical
or ECG features of cardiomyopathy (30,42–44).
CONSIDERATIONS IN ATHLETES AGE 12 TO 16 YEARS:
THE ‘JUVENILE’ ELECTROCARDIOGRAM PATTERN.
TWI confined to the anterior precordial leads may be
considered a normal age-related pattern in adolescent
athletes up to the age of 16 years old. The term
‘juvenile’ ECG pattern is used to denote TWI or a
biphasic T-wave beyond lead V2 in adolescents who
have not reached physical maturity and is present in
10%–15% of white, adolescent athletes aged 12 years
old but only in 2.5% of white athletes age 14 to
15 years (Figure 4A) (22,45,46). Anterior TWI that
extends beyond lead V2 is rare (0.1%) in white
athletes age $16 years or younger athletes who have
completed puberty (22,45). Based on current evi-
dence, TWI in the anterior leads (V1 to V3) in adoles-
cent athletes <16 years of age should not prompt
further evaluation in the absence of symptoms, signs,
or a family history of cardiac disease.
PHYSIOLOGICAL ARRHYTHMIAS IN ATHLETES. Common
consequences of increased vagal tone include sinus
bradycardia and sinus arrhythmia (22,47–49). Other,
less common markers of increased vagal tone are
TABLE 1 International Consensus Standards for Electrocardiographic Interpretation in Athletes: Definitions of ECG Criteria
Abnormal ECG findings in athletes
These ECG findings are unrelated to regular training or expected physiologic adaptation to exercise, may suggest the presence of pathologic







$1 mm in depth in two or more contiguous leads; excludes leads aVR, III, and V1
 V2–V4
– excludes: black athletes with J-point elevation and convex ST-segment elevation followed by
TWI in V2–V4; athletes age <16 with TWI in V1–V3; and biphasic T waves in only V3
 I and AVL, V5 and/or V6 (only one lead of TWI required in V5 or V6)
 II and aVF, V5–V6, I and AVL
 II and aVF
ST-segment depression $0.5 mm in depth in two or more contiguous leads
Pathologic Q waves Q/R ratio $0.25 or $40 ms in duration in two or more leads (excluding III and aVR)
Complete left bundle branch block QRS $120 ms, predominantly negative QRS complex in lead V1 (QS or rS), and upright notched or slurred
R wave in leads I and V6
Profound nonspecific intra-ventricular
conduction delay
Any QRS duration $140 ms
Epsilon wave Distinct low amplitude signal (small positive deflection or notch) between the end of the QRS complex and
onset of the T-wave in leads V1–V3
Ventricular pre-excitation PR interval <120 ms with a delta wave (slurred upstroke in the QRS complex) and wide QRS ($120 ms)
Prolonged QT interval* QTc $470 ms (male)
QTc $480 ms (female)
QTc $500 ms (marked QT prolongation)
Brugada Type 1 pattern Coved pattern: initial ST-segment elevation$2 mm (high take-off) with downsloping ST-segment elevation
followed by a negative symmetric T-wave in $ 1 leads in V1–V3
Profound sinus bradycardia <30 beats/min or sinus pauses $3 s
Profound 1 AV block $400 ms
Mobitz Type II 2 AV block Intermittently non-conducted P waves with a fixed PR interval
3 AV block Complete heart block
Atrial tachyarrhythmias Supraventricular tachycardia, atrial fibrillation, atrial flutter
PVC $2 PVCs per 10 s tracing
Ventricular arrhythmias Couplets, triplets, and non-sustained ventricular tachycardia
Borderline ECG findings in athletes
These ECG findings in isolation likely do not represent pathologic cardiovascular disease in athletes, but the presence of two or more borderline
findings may warrant additional investigation until further data become available.
ECG abnormality Definition
Left axis deviation 30 to 90
Left atrial enlargement Prolonged P wave duration of >120 ms in leads I or II with negative portion of the P-wave $1 mm in depth
and $40 ms in duration in lead V1
Right axis deviation >120
Right atrial enlargement P-wave $2.5 mm in II, III, or aVF
Complete right bundle branch block rSR0 pattern in lead V1 and a S wave wider than R wave in lead V6 with QRS duration $120 ms
Continued on the next page
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junctional or ectopic atrial rhythms, first degree atrio-
ventricular (AV) block, and Mobitz Type I second de-
gree AV block (Wenckebach phenomenon) (22,47,50).
In the absence of symptoms, heart rates$ 30 beats/min
are considered normal in highly trained athletes.
Sinus rhythm should resume and bradycardia should
resolve with the onset of physical activity.
BORDERLINE ELECTROCARDIOGRAM
FINDINGS IN ATHLETES
Recent data suggest that some ECG findings previ-
ously categorized as abnormal may represent normal
variants or the result of physiological cardiac
remodeling in athletes and do not usually represent
pathological cardiac disease. These ECG findings have
been categorized as ‘borderline’ findings in athletes
(Figure 1, Table 1).
AXIS DEVIATION AND VOLTAGE CRITERIA FOR
ATRIAL ENLARGEMENT. Axis deviation and voltage
criteria for atrial enlargement account for >40% of
abnormal ECG patterns in athletes but do not correlate
with cardiac pathology (51). In a large study of 2,533
athletes age 14 to 35 years old and 9,997 controls of
similar age, echocardiographic evaluation of the 579
athletes and controls with isolated axis deviation or
voltage criteria for atrial enlargement failed to identify
any major structural or functional abnormalities (51).
COMPLETE RIGHT BUNDLE BRANCH BLOCK. Although
incomplete right bundle branch block (RBBB) is
common in young athletes, the significance of com-
plete RBBB is less certain. Complete RBBB is detected
in approximately 1% of the general population and
large datasets in young adult athletes reveal a prev-
alence of 0.5% to 2.5% (12,52–54). In a study of 510
U.S. collegiate athletes, RBBB was reported in 2.5%
and compared with athletes with normal QRS com-
plexes or incomplete RBBB, athletes with complete
RBBB exhibited larger right ventricular dimensions
and a lower right ventricular ejection fraction but
preserved fractional area change (55). None of the
athletes with complete RBBB or incomplete RBBB was
found to have pathological structural cardiac disease.
These patterns among trained athletes could repre-
sent a spectrum of structural and physiological
cardiac remodeling characterized by RV dilation with
resultant QRS prolongation and a relative reduction
in the RV systolic function at rest (55).
Based on the aforementioned considerations, left
axis deviation, left atrial enlargement, right axis
deviation and right atrial enlargement and complete
RBBB are considered borderline variants in athletes.
The presence of any one of these findings in isolation
or with other recognized physiological electrical pat-
terns of athletic training does not warrant further
assessment in asymptomatic athletes without a fam-
ily history of premature cardiac disease or SCD.
Conversely, the presence of more than one of these
borderline findings places the athlete in the abnormal
category warranting additional investigation.
TABLE 1 Continued
Normal ECG findings in athletes
These training-related ECG alterations are physiologic adaptations to regular exercise, considered normal variants in athletes, and do not require
further evaluation in asymptomatic athletes with no significant family history.
Normal ECG finding Definition
Increased QRS voltage Isolated QRS voltage criteria for left (SV1 þ RV5 or RV6 >3.5 mV) or right ventricular hypertrophy
(RV1 þ SV5 or SV6 >1.1 mV)
Incomplete RBBB rSR0 pattern in lead V1 and a qRS pattern in lead V6 with QRS duration <120 ms
Early repolarization J-point elevation, ST-segment elevation, J waves, or terminal QRS slurring in the inferior and/or lateral leads
Black athlete repolarization variant J-point elevation and convex (‘domed’) ST-segment elevation followed by T-wave inversion in leads V1–V4
in black athletes
Juvenile T-wave pattern T-wave inversion V1–V3 in athletes age <16 yrs
Sinus bradycardia $30 beats/min
Sinus arrhythmia Heart rate variation with respiration: rate increases during inspiration and decreases during expiration
Ectopic atrial rhythm P waves are a different morphology compared with the sinus P-wave, such as negative P waves in the
inferior leads (‘low atrial rhythm’)
Junctional escape rhythm QRS rate is faster than the resting P-wave or sinus rate and typically <100 beats/min with narrow QRS
complex unless the baseline QRS is conducted with aberrancy
1 AV block PR interval 200–400 ms
Mobitz Type I (Wenckebach)
2 AV block
PR interval progressively lengthens until there is a non-conducted P-wave with no QRS complex; the first
PR interval after the dropped beat is shorter than the last conducted PR interval
*The QT interval corrected for heart rate is ideally measured using Bazett’s formula with heart rates between 60 and 90 beats/min; preferably performed manually in lead II or
V5 using the teach-the-tangent method
1 to avoid inclusion of a U-wave (please see text for more details). Consider repeating the ECG after mild aerobic activity for a heart rate
<50 beats/min, or repeating the ECG after a longer resting period for a heart rate >100 beats/min, if the QTc value is borderline or abnormal.
AV ¼ atrioventricular block; ECG ¼ electrocardiogram; PVC ¼ premature ventricular contraction; RBBB ¼ right bundle branch block.
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TABLE 2 Evaluation of Electrocardiographic Abnormalities
ECG Abnormality Potential Cardiac Disease* Recommended Evaluation† Considerations











Minimum 24 h ECG monitor
Lateral or inferolateral T wave inversion is common in primary
myocardial disease. CMR should be a routine diagnostic
test for this ECG phenotype and is superior to
echocardiography for detecting apical HCM, LVH localized
to the free lateral wall, ARVC with predominant left
ventricular involvement, and myocarditis.
If CMR is not available, echocardiography with contrast should
be considered as an alternative investigation for apical
HCM in patients with deep T wave inversion in leads V5–V6.
Consider family evaluation if available and genetic screening.
Annual follow-up testing is recommended throughout athletic
career in athletes with normal results.






Echocardiography Consider CMR based on echocardiography findings or
clinical suspicion.







Minimum 24 h ECG monitor
SAECG
The extent of investigations may vary based on clinical






Echocardiography Consider CMR and additional testing based on
echocardiography findings or clinical suspicion.






CAD risk factor assessment
Repeat ECG for septal (V1–V2) QS
pattern; above investigations
recommended if septal Q waves are
persistent
Consider CMR (with perfusion study if available) based on
echocardiography findings or clinical suspicion.
In the absence of CMR, consider exercise stress testing,
dobutamine stress echocardiogram, or a myocardial
perfusion scan for evaluation of coronary artery disease in
athletes with suspicion of prior MI or multiple risk factors
for CAD.








CMR (with stress perfusion study)§
A comprehensive cardiac evaluation to rule out myocardial







Echocardiography Consider additional testing based on echocardiography
findings or clinical suspicion.
Epsilon wave ARVC Echocardiography
CMR
Exercise ECG test
Minimum 24 h ECG monitor
SAECG
An epsilon wave in leads V1-V3 is a highly specific ECG maker










24 h ECG monitor
Exercise ECG test
If >2,000 PVC’s or non-sustained ventricular tachycardia are
present on initial testing, comprehensive cardiac testing
inclusive of CMR is warranted to investigate for myocardial
disease.
Consider signal averaged ECG (SAECG).
Ventricular pre-excitation WPW Exercise ECG test
Echocardiography
Abrupt cessation of the delta wave (pre-excitation) on exercise
ECG denotes a low risk pathway.
EP study for risk assessment should be considered if a low risk
accessory pathway cannot be confirmed by non-invasive
testing.
Consider EP study for moderate to high intensity sports.
Prolonged QTc LQTS Repeat resting ECG on separate day
Review for QT prolonging medication
Acquire ECG of 1st degree relatives if
possible
Consider exercise ECG test, laboratory (electrolyte) screening,
family screening and genetic testing when clinical suspicion
is high.
Consider direct referral to a heart rhythm specialist or sports
cardiologist for a QTc $500 ms.
Brugada Type 1 pattern Brugada syndrome Referral to cardiologist or heart
rhythm specialist
Consider high precordial lead ECG with leads V1 and V2 in 2nd
intercostal space or sodium channel blockade if Brugada
pattern is indeterminate.
Consider genetic testing and family screening.









Repeat ECG after mild aerobic activity
Exercise ECG test
Consider additional testing based on clinical suspicion.
Continued on the next page
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The abnormal findings defined in this section are not
recognized features of athletic training and always
require further assessment to exclude the presence of
intrinsic cardiac disease (Figure 1, Tables 1 and 2).
Temporary restriction from athletic activity should
be considered for athletes with abnormal ECGs of
uncertain clinical significance until secondary in-
vestigations are completed.
ABNORMAL T-WAVE INVERSION. TWI $1 mm in
depth in two or more contiguous leads (excluding
leads aVR, III, and V1) in an anterior, lateral, infero-
lateral, or inferior territory is abnormal and should
prompt further evaluation for underlying structural
heart disease (Tables 1 and 2). Normal exceptions
include TWI confined to leads V1–V4 in black athletes
when preceded by J point and/or ST-segment eleva-
tion, and TWI in leads V1–V3 in athletes aged< 16 years.
CLINICAL CONSIDERATIONS. The relationship between
abnormal TWI and several forms of structural heart
disease is well documented (56). TWI in the inferior or
lateral leads is common in HCM (56–59). Whereas TWI
in the right precordial leads (V1 to V3) or beyond in the
absence of a complete RBBB is common in ARVC
(Figure 4D) (60,61).
There are no data relating to the significance of
flat or biphasic T-waves in athletes but similar to
TWI, this panel would recommend further evaluation
of biphasic T-waves where the negative portion is
$1 mm in depth in $2 leads.
Evaluat ion . Lateral or inferolateral T-wave inversion.
There is mounting evidence that TWI in the lateral or
inferolateral leads is associated with the presence of
quiescent cardiomyopathy in a considerable propor-
tion of athletes (30,62–64). Recommendations for the
evaluation of abnormal TWI and other clinical con-
siderations are presented in Table 2.
TWI affecting the lateral leads (V5 to V6, I and aVL)
(Figure 4E) should prompt a comprehensive investi-
gation to exclude cardiomyopathy. If echocardiogra-
phy is not diagnostic, cardiac magnetic resonance
imaging (MRI) with gadolinium should be utilized.
Cardiac MRI provides superior assessment of
myocardial hypertrophy, especially the left ventric-
ular apex and the lateral free wall and may also
demonstrate late gadolinium enhancement (LGE), a
non-specific marker suggesting myocardial fibrosis. If
cardiac MRI is not available, echocardiography with
contrast should be considered. Exercise ECG testing
and Holter monitoring also should be considered in
the evaluation of lateral or inferolateral TWI, espe-
cially for athletes with ‘grey zone’ hypertrophy
(males with maximal LV wall thickness 13 to 16 mm)
without LGE, where the diagnosis of HCM remains
uncertain. In such cases, the presence of ventricular
tachycardia during exercise or Holter may support
HCM and is also useful in risk stratification (65).
For athletes with lateral or inferolateral TWI, reg-
ular follow-up with serial cardiac imaging is neces-
sary even when the initial evaluation is normal, in
order to monitor for the development of a cardio-
myopathy phenotype (62,63).
Anterior T-wave inversion. Anterior TWI is a normal
variant in asymptomatic adolescent athletes age
<16 years, in black athletes when preceded by J-point
elevation and convex ST-segment elevation, and in
some endurance athletes (66,67). However, anterior
TABLE 2 Continued
ECG Abnormality Potential Cardiac Disease* Recommended Evaluation† Considerations





Minimum 24 h ECG monitor
Exercise ECG test
Consider laboratory screening and CMR based on
echocardiography findings.
Atrial tachyarrhythmias Myocardial or electrical
disease
Echocardiography
Minimum 24 h ECG monitor
Exercise ECG test
Consider CMR or EP study based on clinical suspicion.




Minimum 24 h ECG monitor
Exercise ECG test
A comprehensive cardiac evaluation to rule out myocardial
disease and primary electrical disease should be
considered.
Two or more borderline ECG
findings
Myocardial disease Echocardiography Consider additional testing based on clinical suspicion.
*This list of disorders for each ECG abnormality represents the primary cardiac disorders of concern and is not intended to be exhaustive. †Initial evaluation of ECG abnormalities should be performed under
the direction of a cardiologist. Additional testing will be guided by initial findings and clinical suspicion based on the presence of symptoms or a family history of inherited cardiac disease or SCD. ‡Excludes
black athlete repolarization variant and juvenile pattern in adolescents < 16 years. §CT coronary angiography if stress perfusion with CMR is unavailable. kIncludes couplets, triplets, accelerated ventricular
rhythm, and non-sustained ventricular tachycardia.
ARVC ¼ arrhythmogenic right ventricular cardiomyopathy; CAD ¼ coronary artery disease; CMR ¼ cardiovascular magnetic resonance; DCM ¼ dilated cardiomyopathy; ECG ¼ electrocadiogram;
EP ¼ electrophysiological; HCM ¼ hypertrophic cardiomyopathy; LQTS ¼ long QT syndrome; LVNC ¼ left ventricular noncompaction; MI ¼ myocardial infarction; PVC ¼ premature ventricular contraction;
SAECG ¼ signal averaged electrocadiogram; WPW ¼ Wolff Parkinson White syndrome.
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TWI in leads V1 to V2/V3 also is a recognized pattern in
patients with ARVC and rarely HCM.
There are discrepancies among existing guidelines
relating to the extent of anterior TWI inversion before
considering further investigations (5,6,14,29). A large
study of over 14,000white adults age 16 to 35 years old,
including over 2,500 athletes showed that anterior TWI
had a prevalence of 2.3% (68). Anterior TWI was more
common in females and athletes and was confined
to leads V1 to V2 in almost all individuals, and only
exceeded beyondV2 in 1% of females and0.2% ofmales
(68). None of the individuals with anterior TWI were
diagnosed with a cardiomyopathy following compre-
hensive investigation indicating that this particular
ECG pattern is non-specific in low-risk populations.
Based on this report, it is justifiable to only investigate
non-black athletes with anterior TWI beyond V2 in the
absence of other clinical or electrical features of ARVC.
Specific information about the J-point and pre-
ceding ST-segment may help differentiate between
physiological adaptation and cardiomyopathy in
athletes with anterior TWI affecting leads V3 and/or
V4. A recent study comparing anterior TWI in a series
of black and white healthy athletes, and patients with
HCM and ARVC, showed that in athletes with anterior
TWI, the combination of J-point elevation $ 1 mm and
TWI confined to leads V1 to V4 excluded either car-
diomyopathy with 100% negative predictive value,
regardless of ethnicity (66). Conversely, anterior TWI
associated with minimal or absent J-point elevation
(<1 mm) could reflect a cardiomyopathy (66). These
data require duplication in larger studies but may
prove useful in the assessment of a small proportion
of white endurance athletes who exhibit anterior TWI
and in athletes of black/mixed ethnicity (69).
In most non-black athletes age $16 years, anterior
TWI beyond lead V2 should prompt further evaluation
given the potential overlap with ARVC. In these
athletes, concurrent findings of J-point elevation,
ST-segment elevation, or biphasic T waves more
likely represents athlete’s heart, while the absence of
J-point elevation or a coexistent depressed ST-
segment is more concerning for ARVC (Figure 5) (66)
Other ECG findings suggestive of ARVC include low
limb lead voltages, prolonged S wave upstroke, ven-
tricular ectopy with LBBB morphology, and epsilon
waves (61). A combination of tests is needed to di-
agnose ARVC including echocardiography, cardiac
MRI, Holter monitoring, exercise ECG test, and signal
averaged ECG.
FIGURE 2 Early Repolarization Changes in an Athlete
Electrocardiogram of a 29-year-old male asymptomatic soccer player showing sinus bradycardia (44 beats/min), early repolarization in I, II, aVF, V2 to V6 (arrows),
voltage criterion for left ventricular hypertrophy (S-V1 þ R-V5 >35 mm), and tall, peaked T waves (circles). These are common, training related findings in athletes and
do not require more evaluation.
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Inferior T-wave inversion. The significance of TWI
confined to the inferior leads is unknown. However,
this finding cannot be attributed to physiological
remodeling and thus warrants further investigation
with, at minimum, an echocardiogram. Cardiac MRI
should be considered based on the echocardiographic
findings or clinical suspicion.
ST-SEGMENT DEPRESSION. While ST-segment
depression is common among patients with cardio-
myopathy, it is not a feature of athletic training
(28,59,70,71). ST-segment depression (relative to the
isoelectric PR segment) in excess of 0.05 mV (0.5 mm)
in two or more leads should be considered an
abnormal finding requiring definitive evaluation for
underlying structural heart disease.
Evaluat ion . Echocardiography is the minimum
evaluation for athletes with ST-segment depression
to investigate for underlying cardiomyopathy. Car-
diac MRI should be considered based on the echo-
cardiographic findings or clinical suspicion.
PATHOLOGICAL Q WAVES. Several pathological
disorders including HCM, ARVC, infiltrative myocar-
dial diseases, accessory pathways and transmural
myocardial infarction can lead to the development of
exaggerated (deep or wide) Q waves or unexpected Q
waves in atypical leads (28,56). Pathological Q waves
also may be a result of lead misplacement. In partic-
ular, a pseudo-septal infarct pattern with pathological
Q waves in leads V1 to V2 is commonly due to high-
lead placement relative to cardiac position (72).
Pathological Q waves have been reported in
approximately 1% to 2% of all athletes, and may be
higher in males and black athletes (29,73). For
asymptomatic athletes, pathological Q waves were
previously defined as >3 mm in depth or >40 ms in
duration in two or more leads (except III and aVR)
(6,10). In practice, however, this criterion is a com-
mon source of false positive ECG results as trained
athletes with physiological LVH and thin adolescent
athletes may have increased precordial voltages and
deep lateral or inferior Q waves.
The use of a Q/R ratio overcomes some of
these issues by normalizing Q wave depth to the
degree of proceeding R-wave voltage. Case control
analyses of athletes and HCM patients suggest
that this will decrease the false positive rate
without compromising sensitivity for the detection of
cardiomyopathy (29,74). Thus, this consensus panel
has modified the definition for pathological Q waves
FIGURE 3 Anterior Repolarization Changes in a Black Athlete
Electrocardiogram from a black athlete demonstrating voltage criterion for left ventricular hypertrophy, J-point elevation, and convex (‘domed’) ST-segment elevation
followed by T-wave inversion in V1 to V4 (circles). This is a normal repolarization pattern in black athletes.
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in athletes as a Q/R ratio $0.25 or $40 ms in duration
in two or more contiguous leads (except III and aVR).
Evaluat ion . AnECGwith abnormal Qwaves should be
carefully examined for the possibility of an accessory
pathway. If the pathological Q waves are isolated to
leads V1 to V2, the ECG should be repeated, including
re-placing the ECG leads to ensure proper positioning.
Persistence of pathological Q waves in two or more
contiguous leads warrants further investigation with
echocardiography to exclude cardiomyopathy. If the
echocardiogram is normal and there are no other
concerning clinical findings or ECG abnormalities, no
additional testing is generally necessary. However, if
there is a high index of clinical suspicion, additional
evaluation with cardiac MRI should be considered. In
athlete’s age $30 years with suspicion of prior
myocardial infarction or risk factors for coronary artery
disease (CAD), stress testing may be warranted.
COMPLETE LEFT BUNDLE BRANCH BLOCK. LBBB is
found in <1 in 1,000 athletes but is common in pa-
tients with cardiomyopathy and ischemic heart
FIGURE 4 Normal and Abnormal Patterns of T-Wave Inversion
(A) Anterior T-wave inversion in V1 to V3 in a 12-year-old asymptomatic athlete without a family history of sudden cardiac death considered a normal ‘juvenile’ pattern.
(B) T-wave inversion in V1 to V4 in a 17-year-old asymptomatic mixed race (Middle-Eastern/black) athlete without a family history of sudden cardiac death. This is a
normal repolarization pattern in black athletes. (C) Biphasic T-wave inversion in V3 in a 31-year-old asymptomatic black athlete without a family history of sudden
cardiac death. Anterior biphasic T waves are considered normal in adolescents <16 years old and in adults when found in a single lead, most commonly V3.
(D) Abnormal T-wave inversion in V1 to V6 in an adult symptomatic former soccer player with genetically confirmed arrhythmogenic right ventricular cardiomyopathy
and a positive family history of sudden cardiac death (brother died at 26 years of age). (E) Inferolateral T-wave inversion in leads I, II, III, aVF, V2 to V6, and ST-segment
depression in leads II, aVF, V4 to V6 in a 31-year-old asymptomatic professional soccer referee. These markedly abnormal findings require a comprehensive evaluation
to exclude cardiomyopathy. (F) An electrocardiogram demonstrating the Type 1 Brugada pattern with high take-off ST-segment elevation $ 2 mm with downsloping
ST-segment elevation followed by a negative symmetric T wave in V1 to V2.
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disease (9,28,59,75,76). Thus, complete LBBB always
should be considered an abnormal finding and
requires a comprehensive evaluation to rule out a
pathological cardiac disorder.
Evaluat ion . Athletes with complete LBBB require a
thorough investigation for myocardial disease
including echocardiography and a cardiac MRI with
perfusion study.
PROFOUND NON-SPECIFIC INTRA-VENTRICULAR
CONDUCTION DELAY. Epidemiological studies of
nonspecific intra-ventricular conduction delay (IVCD)
in the general population have shown an increased
risk of cardiovascular death and have been docu-
mented among patients with cardiomyopathy (77,78).
The significance of non-specific IVCD with normal
QRS morphology in healthy, asymptomatic athletes is
uncertain (79). The physiology underlying IVCD in
athletes remains incompletely understood but likely
includes some combination of neurally mediated
conduction fiber slowing and increased myocardial
mass. In patients with LVH, left ventricular mass
seems to be closely related to QRS duration (80).
While the exact cut-off to trigger more investiga-
tion in athletes with a nonspecific IVCD remains
unclear, this panel recommends that marked
nonspecific IVCD $140 ms in athletes, regardless of
QRS morphology, is abnormal and should prompt
further evaluation.
Eva luat ion . In asymptomatic athletes with profound
non-specific IVCD, an echocardiogram is recom-
mended to evaluate for myocardial disease. Other
testing may be indicated depending on echocardio-
graphic findings or clinical suspicion.
VENTRICULAR PRE-EXCITATION. Ventricular pre-
excitation occurs when an accessory pathway by-
passes the AV node resulting in abnormal conduction
to the ventricle (pre-excitation) with shortening of the
PR interval and widening of the QRS. This is evident
on the ECG as the Wolf–Parkinson–White (WPW)
pattern defined as a PR interval <120 ms, the presence
of a delta wave (slurring of the initial QRS), and a QRS
duration >120 ms (81). The WPW pattern occurs in up
to 1 in 250 athletes (9,12,52,82). The presence of an
accessory pathway can predispose an athlete to sud-
den death because rapid conduction of atrial fibrilla-
tion across the accessory pathway can result in VF.
Eva luat ion . A short PR interval in isolation without a
widened QRS or delta wave in an asymptomatic athlete
should not be considered for further assessment. The
WPW pattern warrants further assessment of the
FIGURE 5 Examples of Physiological and Pathological T-Wave Inversion
(A) T-wave inversion in V1 to V4 preceded by J-point elevation and convex ‘domed’ ST-segment elevation (green circles). This should not be
confused with pathological T-wave inversion (B) which demonstrates T-wave inversion in V1 to V6 with absent J-point elevation and a
downsloping ST-segment (red circles).
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refractory period of the accessory pathway. Non-
invasive risk stratification begins with an exercise
stress test, where abrupt, complete loss of
pre-excitation at higher heart rates suggests a low-risk
accessory pathway (83,84). An echocardiogram
also should be considered due to the association of
WPW with Ebstein’s anomaly and cardiomyopathy.
Intermittent pre-excitation during sinus rhythm on
a resting ECG is also consistentwith a low-risk pathway
and may obviate the need for an exercise test (85). If
non-invasive testing cannot confirm a low-risk
pathway or is inconclusive, an electrophysiological
study should be considered to determine the shortest
pre-excited RR interval during atrial fibrillation (83). If
the shortest pre-excited RR interval is #250 ms (240
beats/min), then the accessorypathway is deemedhigh
risk and transcatheter ablation is recommended
(83,86). Some physicians may choose to subject all
competitive athletes involved in moderate or high-
intensity sport to electrophysiological studies
irrespective of the results of the exercise test or 24 h
ECG on the premise that high catecholamine concen-
trations during very intensive exercise may modify
the refractory period of an accessory pathway in
a fashion that cannot be reproduced during laboratory
tests.
PROLONGED QT INTERVAL. Congenital long QT
syndrome (LQTS) is a potentially lethal, genetically
mediated ventricular arrhythmia syndrome with the
hallmark electrocardiographic feature of QT prolon-
gation. LQTS is estimated to affect 1 in 2,000 in-
dividuals, and this may be underestimated given the
subpopulation of so-called ‘normal QT interval’ or
‘concealed’ LQTS (87). Autopsy negative sudden
unexplained death represents 25% to 40% of sudden
unexpected deaths in persons under age 40 years
(3,88–90). In such cases, cardiac ion channelopathies
have been implicated by post-mortem genetic
testing as the probable cause in up to 25% to 40% of
cases (91–94).
Calcu lat ing the corrected QT interva l . Accurate
measurement and manual confirmation of the com-
puter derived QT interval corrected for heart rate
(QTc) is critical as the accuracy of computer generated
QTc values is about 90% to 95%. Studies have sug-
gested the ability of cardiologists to accurately mea-
sure the QTc is suboptimal (95). However, accurate
assessment of the QTc can be achieved by adhering to
the following six principles (96):
1. Use Bazett’s heart rate correction formula (QTc ¼
QT/ORR; note the RR interval is measured in sec-
onds) as population-based QTc distributions most
frequently use Bazett-derived QTc values (97).
2. Bazett’s formula underestimates the QTc at heart
rates <50 beats/min, and overestimates the QTc at
heart rates >90 beats/min. Accordingly, for a
heart rate <50 beats/min, a repeat ECG after mild
aerobic activity is recommended to achieve a
heart rate closer to 60 beats/min. For heart rates
>90 beats/min, a repeat ECG after additional
resting time may help achieve a lower heart rate.
3. If sinus arrhythmia is present with beat to beat
variation in heart rate, an average QT interval and
average RR interval should be used.
4. Leads II and V5 usually provide the best delinea-
tion of the T-wave.
5. Low amplitude U waves, which are common in the
anterior precordial leads, should not be included in
the QT calculation. The ‘Teach-the-Tangent’ or
‘Avoid-the-Tail’ method to delineate the end of the
T-wave should be followed (Figure 6) (96).
6. The morphology of the T-wave, not just the length
of the QT interval, also can suggest the presence of
LQTS (98). For instance, a notched T-wave in the
lateral precordial leads where the amplitude of the
second portion of the T-wave following the notch
is greater than the first portion of the T-wave may
represent LQT-2 even in the absence of overt QT
prolongation.
The easiest and most efficient way to confirm the
computer-derived QTc is to examine lead II and/or
V5 and determine if the manually measured QT in-
terval matches the computer’s QT measurement. If
there is concordance within about 10 ms, one can
trust that the computer can derive accurately an
average RR interval and complete the Bazett’s
calculation. If, however, the manually measured QT
interval is >10 ms different than the computer’s QT
measurement, an average RR interval should be
determined and the QTc recalculated using the
Bazett’s formula.
Corrected QT cut-offs . Given the overlap between
QTc distributions in population-derived cohorts of
healthy individuals compared with patients with
genetically confirmed LQTS, the QTc cut-off value
compelling further evaluation must be chosen care-
fully to balance the frequency of abnormal results and
the positive predictive value for LQTS.
Recent consensus statements on ECG interpreta-
tion in athletes have recommended that male athletes
with a QTc $470 ms and female athletes with a
QTc $480 ms undergo further evaluation for LQTS to
better balance false positive and false negative find-
ings (6,10). These cut-off values are around the
99th percentile and consistent with thresholds
defined by the American Heart Association and
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American College of Cardiology (99). This consensus
group also recommends QTc values of $470 ms in
males and $480 ms in females to define the threshold
of QT prolongation that warrants further assessment
in asymptomatic athletes.
Short QT interval. The precise cut-off and clinical
significance of a short QT interval in athletes is
unknown. Data from over 18,000 asymptomatic
young British individuals found that the prevalence
of a QTc <320 ms is 0.1%; suggesting an abnormal
cut-off value of <320 ms is pragmatic (100).
However, over a mean follow up period of 5.3 years,
none of the individuals with a short QT <320 ms
experienced any adverse events, syncope, or sudden
death (100). Based on the rarity of this finding and
absence of data to suggest long-term morbidity in
asymptomatic athletes, this panel recommends that
a short QT interval only be investigated in the
context of concerning clinical markers.
Evaluat ion . It is critical that an athlete with a single
prolonged QTc reading not be obligated a diagnosis of
LQTS, but rather that these cut-off values trigger the
need for additional evaluation. The importance of
additional evaluation but not a premature diagnosis
of LQTS was demonstrated in a study of 2,000 elite
athletes in which 7 (0.4%) had a prolonged QTc (range
460 to 570 ms) (101). A QTc of <500 ms in the absence
of symptoms or familial disease was unlikely to
represent LQTS. In contrast, a QTc $500 ms was
highly suggestive of LQTS as all three athletes with a
QTc value of >500 ms exhibited one of paradoxical
prolongation of the QTc during exercise, a confirma-
tory genetic mutation, or prolonged QTc in a first-
degree relative (101).
A personal history of syncope or seizures and a
family history of exertional syncope, ‘epilepsy’,
postpartum-timed syncope/seizure, unexplained
motor vehicle accidents, unexplained drowning, and
premature, unexplained sudden death <50 years of
age should be reviewed. If the personal/family history
is positive, the athlete should be referred to an elec-
trophysiologist for further evaluation. If the personal/
family history is negative, a repeat ECG should be
obtained (ideally on a different day). If the follow-up
ECG is below the QTc cut-off values, then no addi-
tional evaluation is needed and the athlete should
be reassured.
If the repeat ECG still exceeds the QTc cut-off
values, then a screening ECG of the athlete’s first
degree relatives (parents and siblings) should be
considered and the athlete should be referred to an
electrophysiologist for the possibility of newly
FIGURE 6 This Figure Illustrates the ‘Teach-the-Tangent’ or ‘Avoid-the-Tail’ Method for Manual Measurement of the QT Interval
A straight line is drawn on the downslope of the T-wave to the point of intersection with the isoelectric line. The U-wave is not included in the
measurement.
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discovered LQTS. Reversible, extrinsic factors, such
as electrolyte abnormalities (hypokalaemia) or the
presence of QT prolonging medications, must also be
evaluated. If an athlete’s ECG shows a QTc $500 ms
and no reversible causes are identified, then the
athlete should be referred immediately to an elec-
trophysiologist as the probability of LQTS and future
adverse events has increased (102). The Schwartz-
Moss scoring system, electrocardiographic features,
stress ECG, provocative testing, and genetic testing
may be needed to clarify the diagnosis and should be
performed and interpreted by a cardiologist familiar
with the disease (103–106).
BRUGADA TYPE 1 PATTERN. Brugada syndrome (BrS)
is an inherited primary electrical disease which pre-
disposes to ventricular tachyarrhythmias and sudden
death during states of enhanced vagal tone. It is
characterized by the distinctive Brugada ECG pattern
which consists of a coved rSr’ pattern, ST-segment
elevation $2 mm, and inversion of the terminal
portion of the T-wave in leads V1, V2, and V3
(Figure 4F). Although three types were described,
only the Type 1 Brugada pattern is now considered
diagnostic (107–109).
The coved ST-segment elevation in Type 1 Brugada
pattern results in a broad r’ and should be distin-
guishable from the upsloping ST-segment elevation
of early repolarization in an athlete. In this regards,
the ‘Corrado index’ measures the ST-segment eleva-
tion at the start of the ST-segment/J-point (STJ)
and 80 ms after the start of the ST-segment (ST80)
(110). In Type 1 Brugada pattern, the downsloping
ST-segment will have a STJ/ST80 ratio >1, while the
initial upsloping of the ST-segment found in early
repolarization patterns in an athlete will produce an
STJ/ST80 ratio <1 (Figure 7).
Evaluat ion . The Type 1 Brugada ECG pattern
should be investigated regardless of symptoms. If
the pattern is unclear, confirm correct lead place-
ment, repeat the ECG if necessary, and perform a
high precordial lead ECG with V1 and V2 placed in
the 2nd or 3rd intercostal space. If the Type 1
pattern is seen on a high-precordial lead ECG,
then referral to an electrophysiologist is indi-
cated. Consideration should be given to potential
accentuating factors for a Brugada-like ECG pattern,
such as hyperkalaemia, fever, medications with
sodium ion channel blocking properties, and lead
placement.
PROFOUND SINUS BRADYCARDIA OR FIRST DEGREE
ATRIOVENTRICULAR BLOCK. Sinus bradycardia and
moderate prolongation of the PR interval (200–399
ms) are recognized features of athletic conditioning.
Although a resting heart rate #30 beats/min or a PR
interval $400 ms may be normal in a well-trained
athlete, it should prompt further evaluation for car-
diac conduction disease.
Evaluat ion . Evaluation of profound sinus brady-
cardia or a markedly increased PR interval should
include assessing the chronotropic response to mild
aerobic activity, such as running on the spot or
climbing stairs. Exercise testing is useful in this
FIGURE 7 Differentiation Between the Brugada ECG Pattern From Early Repolarization (J Point Elevation and Convex ST Segment) in
Athletes
Brugada Type 1 electrocardiogram (left) should be distinguished from early repolarization with ‘convex’ ST-segment elevation in a trained
athlete (right). Vertical lines mark the J-point (STJ) and the point 80 ms after the J-point (ST80), where the amplitudes of the ST-segment
elevation are calculated. The ‘downsloping’ ST-segment elevation in Brugada pattern is characterized by a STJ/ST80 ratio >1. Early repo-
larization patterns in an athlete show an initial ‘upsloping’ ST-segment elevation with STJ/ST80 ratio <1.
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situation to provide an objective measure of the PR
interval and heart rate response to aerobic activity. If
the heart rate increases appropriately and the PR in-
terval normalizes, and the athlete is asymptomatic,
no further testing is necessary. Conversely, further
evaluation should be performed if the heart rate does
not increase or the PR interval does not shorten
appropriately on exertion, the athlete experiences
pre-syncope/syncope, or in athletes with a family
history of cardiac disease or sudden death. Depend-
ing on the clinical scenario, an echocardiogram or
ambulatory ECG monitor may be indicated.
HIGH GRADE ATRIOVENTRICULAR BLOCK. Mobitz
Type II second degree AV block and third degree
(complete) AV block are abnormal findings in ath-
letes. Complete heart block can be confused with AV
dissociation without block; a situation where the
junctional pacemaker is faster than the sinus node,
leading to more QRS complexes than P waves. Inter-
mittent ventricular capture by sinus P waves (result-
ing in an irregular ventricular response) excludes
complete AV block. AV dissociation without block is
the expression of autonomic mismatch between AV
and sinus nodal modulation, but is not pathological.
Like all other functional disturbances, a small exer-
cise load with repeat ECG recording will show reso-
lution of the ECG findings in AV dissociation.
Evaluat ion . If Mobitz II AV block or complete AV
block is detected, further evaluation includes an
echocardiogram, ambulatory ECG monitor, and exer-
cise ECG test. Based on these results, laboratory
testing and cardiac MRI may be considered. Referral
to an electrophysiologist is essential.
MULTIPLE PREMATURE VENTRICULAR CONTRACTIONS.
Multiple ($2) premature ventricular contractions
(PVCs) are uncommon and present in <1% of 12-lead
ECGs in athletes (9,12). Although multiple PVCs are
usually benign, their presence may be the hallmark of
underlying heart disease (111,112). PVCs originating
from the right ventricular outflow tract (LBBB and
inferior axis origin) are considered particularly
benign when associated with a normal ECG, however
this PVC morphology can also be present in patients
with early ARVC particularly when the QRS exceeds
160 ms (113). Therefore, the finding of $2 PVCs on an
ECG should prompt more extensive evaluation to
exclude underlying structural heart disease.
Evaluat ion . The extent of evaluation for $2 PVCs
is controversial and excluding pathology may be
difficult. At a minimum, an ambulatory Holter
monitor, echocardiogram, and exercise stress test
should be performed. The availability of modern
small, leadless ambulatory recorders allows for
longer electrocardiographic monitoring, including
during training and competition, to exclude complex
ventricular arrhythmias. If the Holter and echocar-
diogram are normal and the PVCs suppress with
exercise, no further evaluation is recommended
for an asymptomatic athlete. A previous study has
shown that among athletes with $2,000 PVCs per
24 h, up to 30% were found to have underlying
structural heart disease, compared with 3% and 0%
in those with <2,000 and <100 PVCs per day,
respectively (112). Therefore, in athletes with $2,000
PVCs per 24 h or with episodes of non-sustained
ventricular tachycardia, or with an increasing
burden of ectopy during an incremental exercise
test, additional evaluation may include contrast-
enhanced cardiac MRI and more invasive electro-
physiology study (114,115). Although some studies
have suggested that regression of the PVC burden
with detraining indicates a good prognosis, other
studies have not confirmed this (116–118). Thus,
detraining as a diagnostic or therapeutic measure is
not recommended.
ATRIAL TACHYARRHYTHMIAS. Sinus tachycardia is
the most common atrial tachyarrhythmia but is very
rarely due to intrinsic cardiac disease. Supraventric-
ular tachycardia (SVT), atrial fibrillation, and atrial
flutter are rarely seen on a resting ECG in athletes and
require investigation. Atrial tachyarrhythmias are
rarely life threatening but can be associated with
other conditions that can lead to SCD, including
LQTS, WPW, BrS, myocarditis, congenital heart dis-
ease, and the cardiomyopathies.
Eva luat ion . If resting sinus tachycardia >120 beats/
min is seen, a repeat ECG should be considered after a
period of rest as recent exercise or anxiety may be the
cause. Other underlying etiologies may be sought,
including fever, infection, dehydration, stimulant
use, anemia, hyperthyroidism, or, rarely, underlying
cardiac or pulmonary disease.
For paroxysmal SVT, a repeat ECG when not in SVT
should be obtained if possible. If the Valsalva ma-
neuver, carotid sinus massage, or the diving reflex is
used to terminate the arrhythmia, a rhythm strip
should be obtained which can help elucidate the
mechanism of the SVT. An echocardiogram, ambula-
tory ECG monitor, and exercise treadmill test should
be completed. Referral to an electrophysiologist may
be indicated for consideration of electrophysiology
study and ablation.
If atrial fibrillation or flutter is found, an echocar-
diogram should be completed to assess for structural
heart disease and anti-coagulation considered based
on standard guidelines (119). An ambulatory ECG
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monitor should be used to assess if the rhythm is
paroxysmal or persistent and what the ventricular
rate is throughout the day. A thorough family history
may elucidate an underlying genetic cause. Depend-
ing on what these results show, cardiac MRI, elec-
trophysiology study with possible ablation, and/or
genetic testing may be considered.
VENTRICULAR ARRHYTHMIAS. Ventricular couplets,
triplets, and non-sustained ventricular tachycardia
always require investigation as they can be a marker
for underlying cardiac pathology or lead to sustained
ventricular tachycardia which may cause SCD.
Evaluat ion . If ventricular arrhythmias are seen, the
evaluation should include a thorough family history,
an echocardiogram to evaluate for structural heart
disease, cardiac MRI to assess for ARVC or other car-
diomyopathies, ambulatory ECG monitor and exer-
cise ECG test. Depending on these results, further
evaluation may be needed including electrophysi-
ology study or genetic testing.
CONSIDERATIONS IN ATHLETES ‡30 YEARS OF
AGE. In athletes $30 years of age, CAD is the most
common cause of SCD (89,90). In addition, older
athletes may be less fit compared with 20 to 30 years
ago, increasing the possibility of underlying CAD
(120,121). While resting ECGs have a low sensitivity
for CAD, some ECG patterns may suggest underlying
CAD such as TWI, pathological Q waves, ST-segment
depression, left or RBBB, abnormal R-wave progres-
sion, left anterior hemiblock, and atrial fibrillation
(122–124).
Evaluat ion . The main role of a resting ECG in older
athletes is to identify those athletes who may
potentially be at high risk for CAD and warrant
further testing (123,125,126). Initial testing should
include an exercise stress test, resting echocardio-
gram, and assessment of traditional risk factors for
CAD. When indicated, this evaluation may be com-
plemented by coronary CT angiography or a func-
tional stress test.
ELECTROCARDIOGRAM PATTERNS REQUIRING
SERIAL EVALUATION. Several common heritable
cardiomyopathies may present with ECG abnormal-
ities prior to the onset of overt heart muscle pathol-
ogy (62,63). Therefore, athletes with abnormal ECGs
suggestive of cardiomyopathy and initially normal
clinical evaluations should be followed with serial
evaluation during and after their competitive athletic
careers. Evaluations may be conducted annually or
more frequently depending on individual circum-
stances. These athletes may be permitted to partici-
pate in competitive athletics without restriction
contingent on longitudinal follow-up.
CONCLUSION
Accurate ECG interpretation in athletes requires
adequate training and an attention to detail to
distinguish physiological ECG findings from abnormal
ECG findings that might indicate the presence of
cardiac pathology. The international consensus
standards presented on ECG interpretation and the
evaluation of ECG abnormalities serve as an impor-
tant foundation for improving the quality of cardio-
vascular care of athletes. As new scientific data
become available, revision of these recommendations
may be necessary to further advance the accuracy of
ECG interpretation in the athletic population.
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